Imagine being able to prevent COVID-19 and the common cold with just a simple nasal spray. This might just become a reality, thanks to a recent study that shows promising results. Researchers have found that an allergy medicine, azelastine, can significantly reduce the chance of getting ill from COVID-19 or the common cold. But here's where it gets controversial - could this be the solution we've been searching for, or is it just a temporary fix?
The study, published on September 2, involved 450 adults who were given azelastine, an antihistamine sold under the brand names Astepro and Astelin. The results showed that those who took the medication were much less likely to contract viral infections than those who took a placebo. But what does this mean for the general public, and how effective is it in real-world scenarios?
Dr. William Schaffner, a professor of infectious diseases at Vanderbilt University School of Medicine, notes that more testing is needed to determine the effectiveness of nasal sprays in preventing respiratory viruses. 'If we could stop the virus at the front door, that would be great,' he said. 'The front door for these viruses is our nose and that tissue right in the back of our noses.'
The idea of using nasal sprays to prevent respiratory viruses is not new. Research over the past few years has suggested that nasal sprays could help prevent COVID-19, the flu, and the common cold. However, larger studies are needed to confirm these findings.
One of the most significant advantages of nasal sprays is that they can be used to attack or block the virus at the source. Viruses must attach to and enter cells to make you sick, and the most common entry point for respiratory viruses is the nose. Scientists believe that medications given through the nose have the potential to be more effective than those injected into the body.
But, there are some challenges to consider. The azelastine study found that sustained use of the antihistamine is needed to provide protection. The study's authors suggested that it could be used before going into high-risk settings, such as large gatherings or travel. However, more research is needed to determine how often and for how many days it should be used.
Other nasal sprays are also being developed, including gels that could almost fully block virus transmission. However, these gels would need to be reapplied regularly, which could be a challenge for people to maintain.
Dr. Sharon Nachman, chief of pediatric infectious diseases at Stony Brook Medicine, notes that antihistamines work by blocking a chemical that causes allergic symptoms. But, she cautions against using azelastine to prevent COVID-19 or colds until after a larger study is conducted and analyzed.
The increase in research into nasal sprays in recent years is in part due to efforts to find more effective vaccines against COVID-19. Current COVID-19 vaccines are effective at preventing severe disease, but their ability to prevent transmission wanes within weeks after the shot is given.
Dr. Paul Spearman, vice chair for clinical and translational research and education at Cincinnati Children's Hospital Medical Center, led the first U.S. human clinical trial of a nasal COVID-19 vaccine. The results showed that people who received higher doses of the spray were significantly less likely to have COVID-19 symptoms than those getting a low dose.
So, what does the future hold for nasal sprays and COVID-19 prevention? While there are still many questions to be answered, one thing is clear - researchers are making progress in finding new and innovative ways to prevent respiratory viruses. As Dr. Spearman notes, 'If you do that, then whenever the virus comes around, your immune cells just take care of it, and ideally, you'd prevent the virus from then getting into the lung or getting in anywhere else where it would make you sick.'
What do you think - could nasal sprays be the key to preventing COVID-19 and the common cold? Share your thoughts in the comments below.
 (Amazon Alexa))